Related by context. All words. (Click for frequent words.) 71 G#D mutation 67 SMN2 gene 67 variant allele 67 EGFR gene 67 PDGFRA 67 HER2 gene 66 tumor specific antigen 66 FTO gene variant 66 HFE gene 65 CFTR gene 65 UGT#A# * 65 pesky fatso gene 65 C#Y 64 C#Y mutation 64 F#del 64 number variations CNVs 64 number variants CNVs 63 RPE# gene 63 myelodysplastic myeloproliferative diseases 63 metastatic malignant 63 MTHFR 63 hypereosinophilic syndrome 62 glutamic acid decarboxylase 62 Vidaza ® 62 papillary renal cell carcinoma 62 chronic eosinophilic leukemia 62 acid phosphatase PAP 62 Heterozygous 62 mutated K ras 62 NF1 gene 61 Familial Adenomatous Polyposis FAP 61 autosomal recessive disorder 61 Nf1 gene 61 MYH9 gene 61 autosomal recessive disease 61 HBeAg negative 61 leukemia AML 61 SHANK3 61 CCL#L# 61 LRAT 61 Naive Patients 61 refractory chronic lymphocytic 61 amylase gene 60 Wwox 60 E4 variant 60 SOD1 gene 60 Kit CD# positive 60 hyperphenylalaninemia HPA due 60 discontinued Viread 60 HLA DRB1 * 60 number variation CNV 60 unmethylated 60 GSTT1 60 Carcinoid tumors 60 ABCB1 60 Ribavirin causes 60 chronic HBV 60 GSTP1 60 relapsed ALL 60 G#D 60 KRAS oncogene 60 K ras mutations 60 Mg Uk 60 K#N 60 FTO allele 60 atypical hemolytic uremic syndrome 59 Lymphocytic 59 NPM1 mutations 59 transthyretin TTR 59 homozygous familial hypercholesterolemia 59 HeFH 59 relapsing remitting MS RRMS 59 BRIP1 59 STK# gene 59 subependymal giant cell 59 vWD 59 CCR5 delta# 59 relapsed MM 59 severe congenital neutropenia 59 Philadelphia Chromosome Positive 59 progranulin gene 59 infantile onset 59 leiomyomas 59 BRCA1 BRCA2 59 nonsense mutation 59 Azacitidine 59 LHRH receptor positive 59 c KIT 59 neuroendocrine cancers 59 orally administered inhibitor 59 apolipoprotein E4 59 cortisol synthesis 59 Intravenous immunoglobulin 59 hemodynamically significant 59 RPE# 59 5 HTT gene 59 Letairis ambrisentan 59 DICER1 gene 59 CDKN2A 59 cutaneous T 59 normal karyotype 59 Waldenstrom macroglobulinemia 59 recurrent metastatic 59 brivanib 59 naïve HCV 59 Mg Usa 59 underwent surgical resection 59 J Am Coll 59 Hodgkin lymphoma HL 59 CYP#C# [002] 59 plasmid encoding 58 unmutated 58 dornase alfa 58 TMPRSS2 ERG fusion 58 homozygous FH 58 SMN1 gene 58 GPC5 58 Acute myeloid leukemia 58 kidney urologic 58 reduce serum phosphate 58 biologic DMARD 58 HLA DQ2 58 replicon 58 stylistic replicas 58 HepG2 cells 58 SOD2 gene 58 gamma globin gene 58 unresectable recurrent 58 oropharyngeal candidiasis OPC 58 tumors GIST 58 somatic mutation 58 novel VDA molecule 58 UGT#B# 58 autoantibody positive 58 Ets2 58 ceftazidime 58 CDH1 58 Retisert R 58 Adenoviral 58 COPEGUS R 58 PEGylated anti 58 pregnancy bacterial vaginosis 58 Chronic lymphocytic leukemia 58 neuroD2 58 gastrointestinal stromal tumors GISTs 58 vitamin B# folic acid 58 CYP#A# CYP#D# 58 vinca alkaloids 58 flutamide 58 H. influenzae 58 aplastic anemia AA 58 CYP#D# gene 58 JAK2 enzyme 58 Nonalcoholic fatty liver 58 chronic granulomatous disease 58 Atypical Hemolytic Uremic Syndrome 58 ApoE gene 57 HCV replicon 57 mycobacterium tuberculosis 57 RTP #i 57 glutamic acid decarboxylase GAD 57 pediatric acute lymphoblastic 57 IMiDs ® compound 57 hypermethylated 57 basal cell carcinoma BCC 57 Orally administered 57 cause cardiac channelopathies 57 RSV infects 57 chronic immune thrombocytopenic 57 smoldering multiple myeloma 57 osteosarcomas 57 PNP inhibitor 57 IgA deficiency 57 Pericardial 57 Endometrial 57 complement inhibitor eculizumab 57 cholesteryl ester transfer 57 cisplatin resistant 57 KRAS mutations occur 57 APOE e4 57 CYT# potent vascular disrupting 57 Myelodysplastic syndromes 57 Ph + acute lymphoblastic 57 dasatinib Sprycel ® 57 familial hypercholesterolemia 57 binds selectively 57 FUSILEV enhances 57 overt nephropathy 57 Escherichia coli Klebsiella pneumoniae 57 AGHD 57 candidemia 57 symptomatic BPH 57 fluoropyrimidine 57 autosomal recessive 57 tetracycline antibiotic 57 predominantly classic subfoveal 57 Int J Radiat Oncol 57 GRNOPC1 contains 57 primary humoral immunodeficiency 57 decompensated liver disease 57 vinorelbine tartrate 57 dasatinib Sprycel 57 PEGylated Fab fragment 57 #mg #mg #mg [003] 57 chronic ITP patients 57 TTR gene 57 HbF 57 BMPR2 57 rheumatoid arthritis osteoarthritis ankylosing 57 Janus kinase 57 Sapacitabine 57 Congenital Emphysema 57 chemoresistant 57 fluconazole resistant 57 INSPIRE Trial Phase III 57 post transplant lymphoproliferative 57 HIV HCV coinfected 57 NRTI resistance 57 nonsense mutations 57 KIF6 gene 57 seropositive patients 57 Systemic lupus erythematosus SLE 57 Paraplatin ® 57 Allogeneic 57 MAGE A3 protein 57 metastatic bladder 57 gastrointestinal stromal tumors 57 refractory chronic myeloid 57 erlotinib Tarceva ® 57 Her2 gene 57 Pharmacokinetics PK 57 testicular germ cell 57 Folfox 57 PIK3CA 57 hepatoma 56 CC genotype 56 SHANK3 gene 56 heterozygous 56 relapsed refractory AML 56 CFTR corrector 56 lymphoid malignancies 56 Gleevec resistant 56 CYP#C# * 56 arthritis PsA 56 apolipoprotein E gene 56 poor metabolizers 56 ovarian endometrial 56 del 5q MDS 56 cromolyn sodium 56 FTO variant 56 HoFH 56 pancreatic enzyme supplements 56 FLT3 mutations 56 rALLy 56 oral nucleoside analogue 56 Non Alcoholic Steatohepatitis 56 siRNAs targeting 56 P aeruginosa 56 Papillary 56 Glioblastoma multiforme GBM 56 PDGFR 56 BRAF V#E 56 Interferon gamma 56 P. aeruginosa infection 56 chronic myeloid 56 metastatic GIST 56 alpha folate receptor 56 cystic fibrosis chronic pancreatitis 56 cervical vaginal 56 HLA B# 56 FOLFOX6 56 squamous cell lung cancer 56 breast carcinoma 56 postmenopausal osteoporotic women 56 immunocompetent 56 Angiotensin Converting Enzyme 56 APOE e4 gene 56 essential thrombocythemia ET 56 Parnate 56 Genotypes 56 Neulasta R 56 C. trachomatis 56 metastatic gastric 56 surgically resected 56 recurrent glioblastoma multiforme 56 non mutated KRAS 56 Saizen ® 56 estrogen receptor antagonist 56 benign prostatic hypertrophy BPH 56 Squamous 56 myocardial infarction ventricular fibrillation 56 Chronic Lymphocytic Leukemia CLL 56 nonalcoholic steatohepatitis NASH 56 carcinoids originate 56 familial adenomatous polyposis 56 mutated p# 56 Moraxella catarrhalis 56 oral squamous cell 56 aggressive systemic mastocytosis 56 promoter methylation 56 chronic idiopathic thrombocytopenic purpura 56 Neovascular Age Related Macular 56 hamartomas 56 Bezielle 56 cisplatin gemcitabine 56 familial ALS 56 FMR1 56 nilotinib Tasigna ® 56 coding exons 56 deletion 5q 56 IAP inhibitor 56 metastatic adenocarcinoma 56 TCF#L# gene 56 alkylating 56 somatic mutations 56 bladder ovarian 56 M. genitalium 56 Diabetic Neuropathy 56 Upregulation 56 T1DM 56 missense mutation 56 Tumor Necrosis Factor 56 CTAP# Capsules 56 glucokinase activators 56 Leukemias 56 chronic HCV genotype 56 Chronic myeloid leukemia CML 56 MGd 56 receptor tyrosine kinase inhibitor 56 trabectedin 56 Phenylketonuria PKU 56 VHL gene 56 l lysine 56 FGFR2 56 Acetate Rectal Suppositories 56 bexarotene 56 leukemia CLL 56 Gamunex C 56 ergot derivatives 56 relapsed leukemia 56 vinca alkaloid 56 hepatocellular carcinomas 56 antiretroviral naive 56 ADPKD 56 Trypanosoma brucei 56 LymphoStat B belimumab 55 ankylosing spondylitis AS 55 androgen receptor gene 55 cetuximab Erbitux R 55 tissue transglutaminase 55 pegylated interferon alpha 55 Sudhir Agrawal D.Phil 55 Myelodysplastic syndromes MDS 55 transthyretin amyloidosis 55 Fragile X gene 55 Chronic Heart Failure 55 Investigational Treatment 55 biliary tract cancer 55 splice variants 55 NFKBIA 55 orally administered synthetic retinoid 55 Hurthle cell 55 Autoantibodies 55 UGT#A# 55 GBM tumors 55 Candida species 55 nonischemic 55 #q# deletion 55 Myelodysplastic Syndrome MDS 55 LRP5 55 substantially excreted 55 IMiDs ® 55 ZOLINZA 55 infliximab monotherapy 55 HIV coinfected 55 Heterozygous Familial Hypercholesterolemia 55 ritonavir boosted protease inhibitor 55 SCN5A 55 Primary Hypercholesterolemia 55 autosomal recessive genetic 55 activating mutations 55 recurrent malignant glioma 55 Li Fraumeni syndrome 55 syngeneic 55 methylenetetrahydrofolate reductase 55 Peginterferon Alfa 2a 55 Complicated Skin 55 Chlamydia trachomatis 55 Factor Receptor 55 alpha1 antitrypsin deficiency 55 GCase 55 Diamyd r 55 ANCA associated 55 Progressive Multifocal Leukoencephalopathy 55 virus HCV protease inhibitor 55 HMGCR 55 HBeAg positive 55 number NCT# ClinicalTrials.gov 55 TNF Tumor Necrosis Factor 55 dyskeratosis congenita 55 dacarbazine DTIC 55 anthracycline taxane 55 p# deficient 55 hormone refractory metastatic prostate 55 HLA DR4 55 vesicular stomatitis virus 55 refractory acute myeloid 55 Arch Surg 55 Hepsera adefovir dipivoxil 55 PLX STROKE targeting 55 Chronic lymphocytic leukemia CLL 55 Albuferon TM 55 PRN FDA Approves 55 Arch Intern Med 55 Inhalation Aerosol 55 dystrophin gene 55 peritumoral brain edema 55 variant alleles 55 asymptomatic carriers 55 recurrent glioblastoma multiforme GBM 55 cancer mCRC 55 SMN2 55 chronic HBV infection 55 Xyfid TM 55 immune thrombocytopenic purpura 55 Temsirolimus 55 nucleotide analogue 55 Evoltra ® 55 Chronic Myelogenous Leukemia 55 pancreatic insufficiency 55 BRAF gene 55 inherited mutations 55 ABSSSI 55 investigational oral inhibitor 55 Severe Sepsis 55 nonsmall cell lung cancer 55 tuberous sclerosis TS 55 Achieves Primary Endpoint 55 resistant hormone refractory 55 lacunar 55 Chemokine Receptor 55 patientswith 55 grade squamous intraepithelial 55 mda 7 55 AML MDS 55 candesartan cilexetil 55 CIMZIA TM certolizumab pegol 55 purpura ITP 55 generation purine nucleoside 55 Sanofi Pasteur Fluzone 55 haematopoietic stem cell 55 HCV genotypes 55 Polymerase Inhibitor 55 intestinal metaplasia 55 Peginterferon alfa 2b 55 vapreotide acetate 55 indinavir Crixivan 55 beta globin gene 55 Patients Treated With 55 Severe Primary IGFD 55 sargramostim 55 selectively binds 55 onset idiopathic hypogonadism 55 prostanoid 55 lysosomal enzyme iduronate 55 anastrazole 55 systemic juvenile idiopathic 55 Bronchiectasis 55 ductal adenocarcinoma 55 tyrosine kinase inhibitor TKI 55 Thiazolidinediones 55 hemorrhagic cystitis 55 PTEN gene 55 ertapenem 55 MLL2 55 MC1R gene 55 treatment naive genotype 55 FLT3 55 #p#.# [001] 55 ribavirin therapy 55 smoldering myeloma 55 diffuse gastric 55 neoplastic cells 55 AIR CF1 55 pDC 55 cyclin dependent kinase inhibitor 55 chronic HCV infection 55 Vidaza R 55 microdeletions 55 enteroviral 55 lung ovary 55 Chronic Idiopathic Constipation 55 adult chronic ITP 55 TTR amyloidosis 55 autosomal 55 weekly intravenous infusions 55 cyclophosphamide methotrexate 55 lung cancer NSCLC 55 TOMM# 55 NS5b 55 adriamycin 55 virus HBV 55 pyridostigmine 55 homozygous 55 NSCLC tumors 55 galiximab 55 hepatorenal syndrome 55 severe malignant osteopetrosis 55 Arranon 55 WAGR syndrome 55 Epstein Barr virus EBV 55 autosomal dominant disorder 55 thrombocytopenic 55 BCG vaccinated 54 Leber congenital amaurosis LCA 54 NASH Huntington 54 regulator CFTR gene 54 nortriptyline Pamelor 54 8mg/kg 54 BDNF gene 54 H#N# monovalent vaccine 54 Sprycel dasatinib 54 DHFR 54 metastatic hormone refractory 54 B CLL 54 dose intramuscular 54 dominantly inherited 54 Trichophyton rubrum 54 Chlamydia pneumoniae 54 pheochromocytoma 54 metastatic neuroendocrine tumors 54 T#I [002] 54 chimeric monoclonal antibody 54 FMR1 gene 54 genetic variants associated 54 colorectal tumor 54 paternally inherited 54 ErbB2 positive 54 Lubiprostone 54 neuroblastoma tumors 54 BRAF gene mutations 54 Relapsing remitting MS 54 Leydig cells 54 fistulizing CD 54 retinoic acid receptor 54 herpes zoster shingles 54 Velcade bortezomib 54 deCODE AF TM 54 Prolongs Survival 54 endostatin 54 metastatic castrate resistant 54 biochemical relapse 54 Systemic Sclerosis 54 #p# [003] 54 hepatocellular cancer 54 Cathepsin B 54 metaplasia 54 www.ccmopportunitybase.com 54 Zorbtive TM 54 homodimer 54 non splenectomized 54 TIMP 54 unresectable stage 54 malignant neoplasm 54 TÎ ² 4 54 Cloretazine 54 ChronVac C R 54 lexidronam injection 54 hepatitis C genotype 54 KRAS wild 54 von Hippel Lindau 54 MAGE A3 ASCI 54 ovarian breast 54 thetreatment 54 basal cell nevus syndrome 54 metastatic renal 54 Soft Tissue Sarcoma 54 clade B 54 germline mutation 54 preferentially bind 54 acute myelogenous leukemia AML 54 OvaRex ® MAb 54 % CI #.#-#.# [003] 54 receptor blocker 54 Relapsed Refractory 54 Synovial 54 antisense therapies 54 tumorigenicity 54 protease inhibitor PI 54 COL#A# 54 Swift Fearless album 54 Nilotinib 54 AVAPRO 54 diagnosed Ph + 54 HER2 expression 54 minimally symptomatic metastatic castrate 54 herpesviruses 54 simplex virus 54 oligodendrogliomas 54 alpha1 antitrypsin AAT deficiency 54 juvenile idiopathic arthritis JIA 54 CFTR cystic fibrosis transmembrane 54 CFH gene 54 acute myeloid 54 nucleoside naive 54 eccrine 54 pilocytic astrocytomas 54 grade cervical intraepithelial 54 benign neoplasms 54 histone deacetylase inhibitor 54 Epidermal Growth Factor Receptor 54 leiomyoma 54 E#F# 54 apoE4 54 unresectable tumors 54 cell lymphoma CTCL 54 chronic HCV 54 Antitumor Activity 54 assay detects 54 cell adhesion molecule 54 Combination REOLYSIN R 54 FLT3 ITD 54 Cutaneous T 54 metastatic dermatofibrosarcoma protuberans DFSP 54 SNP rs# [001] 54 LTBI 54 GH deficiency 54 Inactivated 54 Acute Myeloid Leukaemia AML 54 affidavits implicating 54 fibrosarcoma 54 non CF bronchiectasis 54 Epstein Barr Virus EBV 54 ELACYT 54 ADP receptor antagonist 54 pancreatic neuroendocrine 54 renal cell carcinomas 54 VEGFR2 inhibitor 54 HLA loci 54 tryptase 54 cytogenetic abnormalities 54 micafungin 54 MSH2 54 J Am Acad 54 BRAF protein 54 mRNA transcripts 54 TYGACIL 54 EGFR protein 54 vesicular monoamine transporter 54 COMT gene 54 MECP2 gene 54 systemic lupus erythematosus SLE 54 T2DM 54 non nucleoside inhibitor 54 Uterine cancer 54 osteoporotic vertebral compression fractures 54 bacterium Mycobacterium tuberculosis 54 SGPT 54 Crit Rev 54 elevated triglyceride levels 54 Genotyping Test 54 potentially hepatotoxic 54 mutated gene 54 Cell Mol Physiol 54 http:/www.go#now.com/nb/#Z Note You 54 Refractory Hodgkin Lymphoma 54 trastuzumab Herceptin ® 54 Lafora disease 54 included exfoliative dermatitis 54 IDH1 gene 54 APOE4 54 Completes Patient Enrollment 54 breast carcinomas 54 prostate adenocarcinoma 54 Pten gene 54 severe neutropenia 54 ApoE4 allele 54 bronchogenic carcinoma 54 intraepithelial neoplasia 54 Chronic myeloid leukemia 54 medulloblastoma tumors 54 Sustiva efavirenz 54 euthyroid 54 arsenic trioxide injection 54 GBMs 54 daily subcutaneous injections 54 LRRK2 gene 54 bioavailable testosterone 54 metastatic colorectal 54 IL#B 54 NOMID 54 Regul Integr Comp Physiol 54 Initiates Phase II 54 amoxicillin clavulanate 54 potent inducer 54 J Am Soc 54 Streptococcus pneumoniae Haemophilus influenzae 54 acute GvHD 54 Chronic HCV 54 topical gel formulation 54 antibody MAb 54 upregulates 54 alpha interferons 54 Diabetic Macular Edema 54 RB Nehemiah Broughton 54 carcinoid tumors 54 Herpes zoster 54 pyridoxine 54 heterozygotes 54 microdeletion 54 stage IIIb IV 54 TGFBR1 * 6A 54 AEG# 54 Cimzia ® certolizumab pegol 54 constitutively activated 54 ALN HPN 54 Wafer polifeprosan 54 potent antiproliferative 54 TOP2A 54 Am J Physiol 54 Enterobacter cloacae 54 allelic 54 ACC2 54 gene amplification 54 High Dose quadruples 54 compound ISA# 54 RAV# 54 lung adenocarcinomas 54 AAT deficiency 54 CFTR proteins 54 T#I mutant 54 humanized interleukin 6 54 induced macular edema 54 operable breast cancer 54 III EGFRvIII 54 TRAIL R1 54 histological subtype 54 pneumococci 54 gemcitabine Gemzar 54 Am J Obstet 54 cerebrovascular disorders 54 untreated metastatic melanoma 54 experimental autoimmune encephalomyelitis 54 Systemic lupus erythematosus 54 histologic subtype 54 Irs2 54 latest album Konvicted 54 Omacetaxine 54 APOL1 54 APOC3 54 CD3 + 54 miglustat 54 Intravitreal injections 54 Shustak gave 54 methicillin sensitive 54 Randomized Phase 54 histologically proven 54 LPA gene 54 abnormal cytology 54 Polymorphisms 54 Foxp2 54 CFTR gene mutations 54 Ophena TM 54 nonmetastatic 54 breast cancer genes BRCA1 53 hemodialysis patients 53 advanced adenoma 53 Peginterferon 53 MELAS 53 Aurora Kinase 53 K#R [002] 53 polycythemia vera PV 53 anti PlGF 53 factor HGF 53 hydroxylase 53 exomes 53 bevacizumab Avastin R 53 treatment naïve genotype 53 Shows Promise Against 53 HCV SPRINT 53 murine leukemia virus 53 poly ADP ribose polymerase 53 antiangiogenic agent 53 recurrent epithelial ovarian 53 Lung transplantation 53 IDH2 53 COPEGUS therapy 53 colorectal carcinoma 53 kinesin spindle protein KSP 53 KRAS mutant tumors 53 globin genes 53 Platinol ® cisplatin 53 thymidine kinase 53 symptomless carriers 53 TO AVOID PREGNANCY WHILE 53 p# biomarker 53 myelofibrosis polycythemia vera 53 Alfacell proprietary ribonuclease 53 Neisseria 53 non squamous 53 Tyrosine Kinase Inhibitor 53 4E BP1 53 Pooled Analysis 53 RASSF1A 53 aMCI precursor 53 TP# mutations 53 Adenomas 53 Pegloticase 53 human leukocyte antigen HLA 53 refractory anemia 53 ApoE4 53 Aromatase 53 HLA DR4 immune 53 gastrointestinal stromal tumors GIST 53 Immunomodulatory 53 Glucocorticoids 53 apoptosis proteins 53 HIV uninfected 53 GNAQ 53 Am J Clin 53 plasmacytoid 53 hemagglutinin H 53 MYDICAR ® 53 TMPRSS2 ERG 53 sodium glucose cotransporter 53 adenoviral 53 nadolol 53 Myelofibrosis 53 pancreatic endocrine 53 hereditary deficiency 53 NOTCH1 53 2 methoxyestradiol 53 Trichomonas vaginalis 53 Antitumor 53 e antigen HBeAg 53 eosinophilic asthma 53 lactate dehydrogenase 53 pemphigus vulgaris 53 valine 53 abacavir Ziagen 53 Fas ligand 53 paraganglioma 53 SNPs pronounced snips 53 treat benign prostatic 53 pulmonary Pseudomonas aeruginosa 53 uniparental 53 Heart Circ Physiol 53 CIN2 + 53 thyroxine T4 53 Tanespimycin 53 Ranibizumab 53 Aeolus Pharmaceuticals Announces 53 radiolabeled antibodies 53 chromosome #q# [002] 53 MC4R gene 53 metalloproteinase 53 hepatocellular carcinoma liver 53 #I TM# 53 gemcitabine Gemzar ® 53 RSV infections 53 Leonardo Sbaraglia cited 53 null responder HCV 53 SNT-MC#/idebenone 53 circulating endothelial cells 53 virus HCV infection 53 humans variant Creutzfeldt 53 Aviptadil 53 peptidic compound 53 nucleotide analog 53 methylated DNA 53 advanced metastatic renal 53 seroconverted 53 familial amyloidotic polyneuropathy FAP 53 Ovidrel R Ovitrelle R 53 idiopathic PAH 53 gene APOE4 53 heavily pretreated 53 APOE4 gene 53 Yamanaka recipe 53 neurofibromas 53 Selective Inhibitor 53 Medulloblastoma 53 pathophysiological effects 53 Epigenomics proprietary 53 dosing cohorts 53 NMIBC 53 mg q#h 53 hyper IgE syndrome 53 unresectable inoperable 53 refractory NSCLC 53 lymphoid tumors 53 liver colon rectal 53 FOLOTYN ® 53 underwent resection 53 commercialize deforolimus 53 receptor inhibitor 53 Negative coggins required 53 Meets Primary Endpoint 53 prescription laxative 53 mitoxantrone plus 53 primary generalized tonic 53 LH FSH 53 Alemtuzumab 53 RNAi therapeutic targeting 53 epithelial tumors 53 KSP inhibitor 53 MLH1 53 glucocorticoid induced osteoporosis 53 Human papillomavirus HPV 53 cyclin E 53 apolipoprotein E APOE 53 adipogenic 53 recurrent acute pancreatitis 53 TELINTRA 53 progressive neurodegenerative disorder 53 stranded nucleic acids 53 RhuDex R 53 LHON 53 Atomoxetine 53 urate oxidase 53 Clusterin 53 toenail onychomycosis 53 myeloproliferative neoplasms 53 BARD1 53 external genital lesions 53 uncomplicated influenza 53 weekly subcutaneous injections 53 erythematosus SLE 53 HER2 receptor 53 sexually transmitted HPV 53 Intravitreal 53 Leukopenia neutropenia 53 idiopathic myelofibrosis 53 BRAF V#E mutation 53 PTPN# 53 achieved ACR# 53 Plasmodium ovale 53 HER2 HER2 53 Vitrasert R 53 gene deletions 53 supratentorial 53 PD LID 53 NNRTI resistance 53 BRCA1 mutation carriers 53 Sezary syndrome 53 pancreatic neuroendocrine tumors 53 sCJD 53 DEB# 53 selectively inhibited 53 Lenalidomide 53 somatostatin 53 HLA DR2 53 dexrazoxane 53 Amgen Neulasta R 53 oral ghrelin agonist 53 gene locus 53 hematologic disorders 53 G allele 53 proband 53 Lymphoid 53 del 5q 53 Kuvan sapropterin dihydrochloride 53 octreotide implant 53 virulence determinants 53 HER2 overexpression 53 Warner Chilcott Actonel 53 gastric carcinoma 53 Monopril 53 interferon alfa 2a 53 radezolid 53 C1 INH deficiency 53 Doxil ® 53 interferon IFN 53 http:/www.go#now.com/nb/#X Note You 53 irreversible inhibitor 53 tumor xenograft models 53 R Saizen R 53 immunocompetent adults 53 M2 subunit 53 dihydrochloride 53 IMiDs R 53 Piperacillin 53 5q chromosome 53 histone deacetylation 53 pancreatic prostate 53 Bordetella pertussis 53 muscular dystrophy cystic fibrosis 53 mesangial 53 Orthop Surg 53 protein encoded 53 androgen receptor antagonist 53 CMV infection 53 castrate resistant prostate cancer 53 Hutchinson Gilford progeria 53 Pneumococcal pneumonia 53 omega interferon 53 BARACLUDE ® 53 relapsed mantle 53 cytarabine daunorubicin